Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial
Elise van Mulligen, A. Weel, T. Martijn Kuijper, N. H. A. M. Denissen, Andreas Gerards, M. H. de Jager, Wai‐Kwan Lam‐Tse, Johanna M. W. Hazes, Annette H M van der Helm–van Mil, Pascal H P de Jong, Jolanda J. Luime
Topics & Concepts
TaperingMedicineRheumatoid arthritisInternal medicineQuality-adjusted life yearCost-effectiveness analysisRheumatologyArthritisQuality of life (healthcare)Cost effectivenessPhysical therapySurgeryComputer graphics (images)NursingComputer scienceRisk analysis (engineering)Rheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsAutoimmune and Inflammatory Disorders Research